PDGF regulated migration of mesenchymal stem cells towards malignancy acts via the PI3K signaling pathway.

INTRODUCTION Mesenchymal stem cells (MSCs) have been described in breast cancer models to migrate towards carcinoma and integrate into tumor associated stroma supporting tumor growth, increasing their metastatic potency and contributing to tumor-angiogenesis. Platelet-derived growth factor (PDGF) isoforms (AA, BB, CC) stimulate growth, survival and motility of MSCs and certain other cell types. Noteworthy, breast carcinomas are known to express PDGF. We aim to further shed light on i) the relevance of the different PDGF isoforms on adipose tissue derived stem cells (ASCs) migration and ii) the underlying pathway dependent on PDGF stimulation. MATERIALS AND METHODS Breast cancer cell lines were purchased and ASC's were isolated from murine subcutaneous adipose tissue. The transmigration of ASC's towards the PDGF-isoforms was assessed by using recombinant human PDGF-AA, PDGF-BB and PDGF-CC in a trans-well culture dish system. Transmigrated ASC's were quantified in 5 randomly selected fields per condition using fluorescence microscopy after calcein-staining. PDGF-BB depended transmigration of ASC's was verified by downregulation and overexpression of PDGF-BB in breast cancer cell line using lentiviral vectors. In addition, a PI3-kinase inhibitor (LY294002) and a MAP-kinase inhibitor (PD98059) were used to identify the pathway involved in the PDGF-BB mediated migration of ASC's towards tumor. RESULTS ASC's transmigration significantly increased towards PDGF AA at 50 ng and only showed further increase by 500 ng which was similar to cell behavior when exposed to PDGF CC. In comparison, PDGF-BB significantly increased ASC's transmigration already at a low level of 5 ng with further significant increase for 20 ng and 40 ng. Cell transmigration was blocked with PDGFR-α antibodies but only for PDGF-AA and PDGF-CC whereas PDGFR-β blockage showed a significant effect on transmigration for PDGF-BB and PDGF-CC but not for PDGF-AA. Neutralizing antibodies in combination with PDGF receptor blockage confirmed findings. In addition, only PI3-kinase inhibitor but not the MEK-1 selective inhibitor caused a significant decrease of transmigration for ASCs towards breast cancer cells. DISCUSSION The transmigration of ASC's is most significantly enhanced by PDGF-BB via the PI3-kinase pathway. This data support that PI3-kinase is an important key player for MSC migration towards malignancy which need further research to prevent tumor progression in early disease stage.

[1]  L. Cerchia,et al.  Inhibition of Bone Marrow-Derived Mesenchymal Stem Cells Homing Towards Triple-Negative Breast Cancer Microenvironment Using an Anti-PDGFRβ Aptamer , 2017, Theranostics.

[2]  L. Cerchia,et al.  Aptamer Functionalization of Nanosystems for Glioblastoma Targeting through the Blood-Brain Barrier. , 2017, Journal of medicinal chemistry.

[3]  M. Krampera,et al.  Mesenchymal stromal cells’ role in tumor microenvironment: involvement of signaling pathways , 2017, Cancer biology & medicine.

[4]  P. Johann,et al.  Multipotent Mesenchymal Stromal Cells: Possible Culprits in Solid Tumors? , 2015, Stem cells international.

[5]  A. Andres,et al.  Human Adipose-Derived Mesenchymal Stromal Cells May Promote Breast Cancer Progression and Metastatic Spread , 2015, Plastic and reconstructive surgery.

[6]  T. Kalber,et al.  Macrophage Migration Inhibitory Factor–CXCR4 Is the Dominant Chemotactic Axis in Human Mesenchymal Stem Cell Recruitment to Tumors , 2015, The Journal of Immunology.

[7]  S. Clément,et al.  Inflammatory Chemokines MIP-1δ and MIP-3α Are Involved in the Migration of Multipotent Mesenchymal Stromal Cells Induced by Hepatoma Cells. , 2015, Stem cells and development.

[8]  Silvia Catuogno,et al.  Inhibition of receptor signaling and of glioblastoma-derived tumor growth by a novel PDGFRβ aptamer. , 2014, Molecular therapy : the journal of the American Society of Gene Therapy.

[9]  L. Prantl,et al.  Adipose Tissue-Derived Stem Cell Secreted IGF-1 Protects Myoblasts from the Negative Effect of Myostatin , 2014, BioMed research international.

[10]  M. Hung,et al.  Mesenchymal stem cells promote growth and angiogenesis of tumors in mice , 2013, Oncogene.

[11]  Ling Huang,et al.  Exosomes derived from human bone marrow mesenchymal stem cells promote tumor growth in vivo. , 2012, Cancer letters.

[12]  G. Tanentzapf,et al.  In vivo functional analysis reveals specific roles for the integrin-binding sites of talin , 2011, Journal of Cell Science.

[13]  J. Vykoukal,et al.  Breast cancer cells attract the migration of adipose tissue-derived stem cells via the PDGF-BB/PDGFR-beta signaling pathway. , 2010, Biochemical and biophysical research communications.

[14]  Naoki Shinojima,et al.  Platelet‐Derived Growth Factor BB Mediates the Tropism of Human Mesenchymal Stem Cells for Malignant Gliomas , 2010, Neurosurgery.

[15]  Yao‐Hua Song,et al.  Tissue resident stem cells produce CCL5 under the influence of cancer cells and thereby promote breast cancer cell invasion. , 2009, Cancer letters.

[16]  Yao‐Hua Song,et al.  Tissue-resident stem cells promote breast cancer growth and metastasis. , 2009, Carcinogenesis.

[17]  Shayn M Peirce,et al.  IFATS Collection: The Role of Human Adipose‐Derived Stromal Cells in Inflammatory Microvascular Remodeling and Evidence of a Perivascular Phenotype , 2008, Stem cells.

[18]  W. Woodward,et al.  Tumor irradiation increases the recruitment of circulating mesenchymal stem cells into the tumor microenvironment. , 2007, Cancer research.

[19]  Ross Tubo,et al.  Mesenchymal stem cells within tumour stroma promote breast cancer metastasis , 2007, Nature.

[20]  M. Kerin,et al.  Monocyte Chemotactic Protein-1 Secreted by Primary Breast Tumors Stimulates Migration of Mesenchymal Stem Cells , 2007, Clinical Cancer Research.

[21]  L. Ellis,et al.  Overexpression of PDGF-BB decreases colorectal and pancreatic cancer growth by increasing tumor pericyte content. , 2007, The Journal of clinical investigation.

[22]  Jörg Fiedler,et al.  To go or not to go: Migration of human mesenchymal progenitor cells stimulated by isoforms of PDGF , 2004, Journal of cellular biochemistry.

[23]  T. Sjöblom,et al.  Platelet-derived growth factor production by B16 melanoma cells leads to increased pericyte abundance in tumors and an associated increase in tumor growth rate. , 2004, Cancer research.

[24]  C. Betsholtz,et al.  Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors. , 2003, The Journal of clinical investigation.

[25]  H. Hammes,et al.  Endothelium‐specific platelet‐derived growth factor‐B ablation mimics diabetic retinopathy , 2002, The EMBO journal.

[26]  C. Betsholtz,et al.  Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. , 1999, Development.

[27]  B R Johansson,et al.  Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. , 1997, Science.

[28]  R. Reed,et al.  A novel physiological function for platelet‐derived growth factor‐BB in rat dermis. , 1996, The Journal of physiology.

[29]  Philippe Soriano,et al.  Abnormal kidney development and hematological disorders in PDGF beta-receptor mutant mice. , 1994, Genes & development.

[30]  M. Raghunath,et al.  The controversial origin of pericytes during angiogenesis - Implications for cell-based therapeutic angiogenesis and cell-based therapies. , 2018, Clinical hemorheology and microcirculation.

[31]  M. Gossen,et al.  Modulation of the mesenchymal stem cell migration capacity via preconditioning with topographic microstructure. , 2017, Clinical hemorheology and microcirculation.

[32]  M. Müller,et al.  Angiogenesis: the role of PDGF-BB on adipose-tissue derived stem cells (ASCs). , 2011, Clinical hemorheology and microcirculation.

[33]  B. Hennessy,et al.  Adipose tissue derived stem cells differentiate into carcinoma-associated fibroblast-like cells under the influence of tumor derived factors , 2011, Cellular Oncology.

[34]  Michael D. Abràmoff,et al.  Image processing with ImageJ , 2004 .